Bharat Thakrar

2.3k total citations
34 papers, 1.7k citations indexed

About

Bharat Thakrar is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Toxicology. According to data from OpenAlex, Bharat Thakrar has authored 34 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Toxicology. Recurrent topics in Bharat Thakrar's work include Pharmacovigilance and Adverse Drug Reactions (6 papers), Influenza Virus Research Studies (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Bharat Thakrar is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (6 papers), Influenza Virus Research Studies (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Bharat Thakrar collaborates with scholars based in United Kingdom, Switzerland and United States. Bharat Thakrar's co-authors include Paul Elliott, P Walls, Gavin Shaddick, Helen Dolk, Richard Doll, Stephen E. Darby, Chris Grundy, A Wisniewski, Jim Slattery and Lucette Doessegger and has published in prestigious journals such as American Journal of Epidemiology, The Journal of Infectious Diseases and Critical Care Medicine.

In The Last Decade

Bharat Thakrar

31 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bharat Thakrar United Kingdom 22 416 273 251 220 200 34 1.7k
Sholom Wacholder United States 26 1.0k 2.5× 43 0.2× 369 1.5× 102 0.5× 69 0.3× 44 4.3k
Rita Ouellet‐Hellstrom United States 14 187 0.4× 159 0.6× 222 0.9× 23 0.1× 71 0.4× 23 1.6k
Gregory D. Kennedy United States 35 335 0.8× 16 0.1× 162 0.6× 128 0.6× 95 0.5× 141 4.6k
Melvyn S. Tockman United States 38 223 0.5× 6 0.0× 385 1.5× 300 1.4× 19 0.1× 98 5.0k
Michael Fralick Canada 30 463 1.1× 44 0.2× 44 0.2× 94 0.4× 322 1.6× 151 2.9k
Subhash Chandra India 25 428 1.0× 14 0.1× 225 0.9× 158 0.7× 169 0.8× 124 2.3k
Marvin A. Schneiderman United States 24 219 0.5× 5 0.0× 230 0.9× 147 0.7× 32 0.2× 84 3.3k
J. William Eley United States 34 334 0.8× 7 0.0× 108 0.4× 130 0.6× 52 0.3× 56 5.5k
Meyer Balter Canada 27 425 1.0× 16 0.1× 25 0.1× 61 0.3× 67 0.3× 64 2.7k
Ladan Golestaneh United States 22 260 0.6× 17 0.1× 51 0.2× 60 0.3× 467 2.3× 79 2.1k

Countries citing papers authored by Bharat Thakrar

Since Specialization
Citations

This map shows the geographic impact of Bharat Thakrar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bharat Thakrar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bharat Thakrar more than expected).

Fields of papers citing papers by Bharat Thakrar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bharat Thakrar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bharat Thakrar. The network helps show where Bharat Thakrar may publish in the future.

Co-authorship network of co-authors of Bharat Thakrar

This figure shows the co-authorship network connecting the top 25 collaborators of Bharat Thakrar. A scholar is included among the top collaborators of Bharat Thakrar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bharat Thakrar. Bharat Thakrar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reckamp, Karen L., Jorge J. Nieva, Aliki Taylor, et al.. (2019). P1.01-105 US Real-World Management of EGFR-Mutated Advanced NSCLC: Prescribing and Attrition Data from First-To-Second-Line Treatment. Journal of Thoracic Oncology. 14(10). S402–S402. 4 indexed citations
2.
Nieva, Jorge J., Karen L. Reckamp, Aliki Taylor, et al.. (2019). P1.01-96 US Real-World Management of EGFR-Mutated Advanced NSCLC: Survival After First-Line EGFR-Tyrosine Kinase Inhibitor Treatment. Journal of Thoracic Oncology. 14(10). S398–S399.
3.
Gray, Jhanelle E., Bharat Thakrar, Ping‐Hui Sun, et al.. (2018). Treatment (tx) patterns in patients (pts) with lung cancer starting 1st or 2nd generation (1G/2G) EGFR-TKI: A US insurance claims database analysis. Annals of Oncology. 29. ix156–ix157. 6 indexed citations
4.
Wisniewski, A, Andrew Bate, Cédric Bousquet, et al.. (2016). Good Signal Detection Practices: Evidence from IMI PROTECT. Drug Safety. 39(6). 469–490. 106 indexed citations
5.
6.
Juhlin, Kristina, Daniel Soeria‐Atmadja, Bharat Thakrar, & G. Niklas Norén. (2014). Evaluation of Statistical Measures for Adverse Drug Interaction Surveillance. Pharmacoepidemiology and Drug Safety. 23. 294–295. 3 indexed citations
7.
Toovey, Stephen, Eric Prinssen, Craig R. Rayner, et al.. (2012). Post-Marketing Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir: An Updated Review. Advances in Therapy. 29(10). 826–848. 31 indexed citations
8.
Toovey, Stephen, Craig R. Rayner, Eric Prinssen, et al.. (2008). Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir. Drug Safety. 31(12). 1097–1114.
9.
Thakrar, Bharat, et al.. (2007). Detecting signals of drug–drug interactions in a spontaneous reports database. British Journal of Clinical Pharmacology. 64(4). 489–495. 84 indexed citations
10.
Dutkowski, Regina, et al.. (2003). Safety and Pharmacology of Oseltamivir in Clinical Use. Drug Safety. 26(11). 787–801. 91 indexed citations
11.
Dore, Gregory J., David A. Cooper, Catherine Barrett, et al.. (1999). Dual Efficacy of Lamivudine Treatment in Human Immunodeficiency Virus/Hepatitis B Virus–Coinfected Persons in a Randomized, Controlled Study (CAESAR). The Journal of Infectious Diseases. 180(3). 607–613. 123 indexed citations
12.
Wilkinson, Paul, Paul Elliott, Chris Grundy, et al.. (1999). Case-control study of hospital admission with asthma in children aged 5-14 years: relation with road traffic in north west London. Thorax. 54(12). 1070–1074. 93 indexed citations
13.
Corrigan, Brian, Barry Nicholls, Bharat Thakrar, et al.. (1999). Heterogeneity in Systemic Availability of Ondansetron and Granisetron following Oral Administration. Drug Metabolism and Disposition. 27(1). 110–112. 9 indexed citations
14.
Darby, Stephen E., Elise Whitley, P Silcocks, et al.. (1998). Risk of lung cancer associated with residential radon exposure in south-west England: a case-control study. British Journal of Cancer. 78(3). 394–408. 179 indexed citations
15.
Dolk, Helen, Paul Elliott, Gavin Shaddick, P Walls, & Bharat Thakrar. (1997). Cancer Incidence near Radio and Television Transmitters in Great Britain II. All High Power Transmitters. American Journal of Epidemiology. 145(1). 10–17. 104 indexed citations
16.
Holdright, D R, C Knight, Hugh Mulcahy, et al.. (1996). Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram.. Heart. 75(3). 222–228. 67 indexed citations
17.
Turner, John S., C. Morgan, Bharat Thakrar, & J Pepper. (1995). Difficulties in predicting outcome in cardiac surgery patients. Critical Care Medicine. 23(11). 1843–1850. 54 indexed citations
18.
Darby, Stephen E., Richard Doll, Bharat Thakrar, C. R. Rizza, & David Cox. (1990). Time from infection with HIV to onset of AIDS in patients with haemophilia in the UK. Statistics in Medicine. 9(6). 681–689. 29 indexed citations
19.
Darby, Stephen E., C R Muirhead, Richard Doll, G M Kendall, & Bharat Thakrar. (1990). Mortality among United Kingdom servicemen who served abroad in the 1950s and 1960s.. Occupational and Environmental Medicine. 47(12). 793–804. 15 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sholom Wacholder Breakdown of academic impact, for papers by Rita Ouellet‐Hellstrom Breakdown of academic impact, for papers by Gregory D. Kennedy Breakdown of academic impact, for papers by Melvyn S. Tockman Breakdown of academic impact, for papers by Michael Fralick Breakdown of academic impact, for papers by Subhash Chandra Breakdown of academic impact, for papers by Marvin A. Schneiderman Breakdown of academic impact, for papers by J. William Eley Breakdown of academic impact, for papers by Meyer Balter Breakdown of academic impact, for papers by Ladan Golestaneh
Rankless by CCL
2026